Is Immune Checkpoint Inhibition Part of Standard Therapy for Stage III Non-Small Cell Lung Cancer?

被引：0
|
作者：
Patel, Jyoti D. [1 ]
Chmura, Steven J. [2 ]
机构：
[1] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Radiat Oncol, Chicago, IL 60637 USA
来源：
CANCER | 2018年 / 124卷 / 14期
关键词：
RANDOMIZED PHASE-III; CONSOLIDATION; RADIOTHERAPY; CONCURRENT; TRIAL; PEMBROLIZUMAB; CISPLATIN; RADIATION; DOCETAXEL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2878 / 2880
页数：3
相关论文
共 50 条
  • [21] Pneumonitis in Advanced Non-Small Cell Lung Cancer: No Interaction between Immune Checkpoint Inhibition and Radiation Therapy
    Neibart, S. S.
    Malhotra, J.
    Roy, J. A.
    Strom, B. L.
    Jabbour, S. K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E384 - E385
  • [22] Pneumonitis in advanced non-small cell lung cancer: no interaction between immune checkpoint inhibition and radiation therapy
    Neibart, Shane S.
    Malhotra, Jyoti
    Roy, Jason A.
    Strom, Brian L.
    Jabbour, Salma K.
    [J]. JOURNAL OF THORACIC DISEASE, 2023, 15 (05) : 2458 - +
  • [23] Pattern of failure in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy with/without immune checkpoint inhibition.
    Taugner, Julian
    Kasmann, Lukas
    Eze, Chukwuka
    Nieto, Alexander
    Guggenberger, Julian
    Florsch, Benedikt
    Kenndoff, Saskia
    Tufman, Amanda
    Reinmuth, Niels
    Belka, Claus
    Manapov, Farkhad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Neoadjuvant Therapy with Immune Checkpoint Inhibitors in operable non-small cell Lung Cancer
    Hekmat, Khosro
    Bruns, Christiane J.
    [J]. CHIRURG, 2021, 92 (08): : 735 - 735
  • [25] Precision medicine in immune checkpoint blockade therapy for non-small cell lung cancer
    Liu, Xiaoming
    Cho, William C.
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [26] Neoadjuvant immune checkpoint inhibitor therapy in resectable non-small cell lung cancer
    Conroy, Michael R.
    Dennehy, Colum
    Forde, Patrick M.
    [J]. LUNG CANCER, 2023, 183
  • [27] TTF-1 and immune checkpoint therapy in non-small cell lung cancer
    Gumbleton, Matthew
    Snyder, Eric L.
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (03) : 398 - 400
  • [28] PATIENT EXPERIENCE OF IMMUNE CHECKPOINT INHIBITOR THERAPY FOR NON-SMALL CELL LUNG CANCER
    Williams, Loretta A.
    Whisenant, Meagan
    Malveaux, Donna
    Singhi, Eric K.
    Altan, Mehmet
    [J]. ONCOLOGY NURSING FORUM, 2023, 50 (02)
  • [29] Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: Emerging Mechanisms and Perspectives
    Inoue, Hiroyuki
    Okamoto, Isamu
    [J]. LUNG CANCER-TARGETS AND THERAPY, 2019, 10 : 161 - 170
  • [30] Combined modality therapy for stage III non-small cell lung cancer
    Stinchcombe, Thomas E.
    Fried, Daniel
    Morris, David E.
    Socinski, Mark A.
    [J]. ONCOLOGIST, 2006, 11 (07): : 809 - 823
12345